Unlocking the enigma of phenotypic drug tolerance: Mechanisms and emerging therapeutic strategies
Alok K Mishra1, Ritesh P Thakare1, Bela G Santani2
1Division of Microbiology, CSIR-Central Drug Research Institute (CDRI), Jankipuram Extension, Lucknow, Uttar Pradesh, 226031, India; Department of Molecular Cell and Cancer Biology, UMass Chan Medical School, Worcester, MA, 01605, USA.
Abstract:
In the ongoing battle against antimicrobial resistance, phenotypic drug tolerance poses a formidable challenge. This adaptive ability of microorganisms to withstand drug pressure without genetic alterations further complicating global healthcare challenges. Microbial populations employ an array of persistence mechanisms, including dormancy, biofilm formation, adaptation to intracellular environments, and the adoption of L-forms, to develop drug tolerance. Moreover, molecular mechanisms like toxin-antitoxin modules, oxidative stress responses, energy metabolism, and (p)ppGpp signaling contribute to this phenomenon. Understanding these persistence mechanisms is crucial for predicting drug efficacy, developing strategies for chronic bacterial infections, and exploring innovative therapies for refractory infections. In this comprehensive review, we dissect the intricacies of drug tolerance and persister formation, explore their role in acquired drug resistance, and highlight emerging therapeutic approaches to combat phenotypic drug tolerance. Furthermore, we outline the future landscape of interventions for persistent bacterial infections.
Insights
Microbial drug tolerance, a non-genetic survival strategy, complicates antimicrobial resistance. Understanding persistence mechanisms is key to developing new therapies for chronic and refractory infections.
Area of Science:
- Microbiology
- Molecular Biology
- Infectious Diseases
Background:
- Antimicrobial resistance (AMR) is a major global health threat.
- Phenotypic drug tolerance, distinct from genetic resistance, allows microbes to survive antibiotic exposure without mutations.
- Persistence mechanisms are crucial for chronic and recurrent infections.
Purpose of the Study:
- To comprehensively review microbial phenotypic drug tolerance and persister formation.
- To explore the role of tolerance in acquired drug resistance.
- To highlight emerging therapeutic strategies against persistent bacterial infections.
Main Methods:
- Literature review of microbial persistence mechanisms.
- Analysis of molecular pathways involved in drug tolerance.
- Examination of therapeutic interventions for refractory infections.
Main Results:
- Microbial populations utilize diverse strategies like dormancy, biofilms, and L-forms to achieve drug tolerance.
- Key molecular mechanisms include toxin-antitoxin systems, oxidative stress responses, altered metabolism, and (p)ppGpp signaling.
- Understanding these mechanisms is vital for predicting treatment outcomes and designing novel therapies.
Conclusions:
- Phenotypic drug tolerance is a significant challenge in combating antimicrobial resistance.
- Targeting persistence mechanisms offers a promising avenue for treating chronic and difficult-to-eradicate bacterial infections.
- Further research into innovative therapeutic approaches is essential to overcome persistent bacterial infections.
More Related Videos
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
16:26Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
Published on: August 20, 2007
Related Concept Videos
Desensitization and Tachyphylaxis
Drug Abuse and Addiction: Pharmacological Phenomena
Analgesia and Pain Management
Principles of Drug Action
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Treatment Resistant Cancers
Drug Therapy
Antianxiety Medications
